The Transfusion News talks about the use of convalescent
plasma for the treatment of patients with COVID-19… We’ve started stocking the
stuff.
Perhaps COVID-19 *is* more relevant to me than I thought?
| Convalescent Plasma Decreases Mortality for Non-Intubated Patients with Severe COVID-19 | |
 May 27, 2020Based on a preliminary propensity score-matched control study, convalescent plasma is beneficial for non-intubated patients with severe COVID-19. At the Mount Sinai Hospital in New York City, 39 hospitalized patients (average age, 55 years; 64% male) with severe to life-threatening COVID-19 were transfused with [Read More] | |
| Convalescent Plasma for COVID-19 Safe in First 5,000 Patients | |
 May 19, 2020With limited therapies for patients with COVID-19 and a mortality rate of approximately 50% for patients in the ICU, demand is high for convalescent plasma from individuals who have recovered from COVID-19. Convalescent plasma has been requested for [Read More] |
No comments:
Post a Comment